CHIPMOS TECHNOLOGIES INC-ADR (IMOS) Fundamental Analysis & Valuation

NASDAQ:IMOS • US16965P2020

Current stock price

39.75 USD
+2.02 (+5.35%)
Last:

This IMOS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. IMOS Profitability Analysis

1.1 Basic Checks

  • Each year in the past 5 years IMOS has been profitable.
  • In the past 5 years IMOS always reported a positive cash flow from operatings.
IMOS Yearly Net Income VS EBIT VS OCF VS FCFIMOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.09%, IMOS is in line with its industry, outperforming 53.91% of the companies in the same industry.
  • IMOS has a Return On Equity of 2.06%. This is comparable to the rest of the industry: IMOS outperforms 53.04% of its industry peers.
  • IMOS has a Return On Invested Capital (2.59%) which is in line with its industry peers.
  • IMOS had an Average Return On Invested Capital over the past 3 years of 3.23%. This is significantly below the industry average of 10.52%.
Industry RankSector Rank
ROA 1.09%
ROE 2.06%
ROIC 2.59%
ROA(3y)2.77%
ROA(5y)5.54%
ROE(3y)5.11%
ROE(5y)9.94%
ROIC(3y)3.23%
ROIC(5y)5.95%
IMOS Yearly ROA, ROE, ROICIMOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • IMOS has a Profit Margin (2.07%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of IMOS has declined.
  • IMOS's Operating Margin of 4.77% is in line compared to the rest of the industry. IMOS outperforms 53.91% of its industry peers.
  • In the last couple of years the Operating Margin of IMOS has declined.
  • IMOS has a worse Gross Margin (10.83%) than 86.09% of its industry peers.
  • In the last couple of years the Gross Margin of IMOS has declined.
Industry RankSector Rank
OM 4.77%
PM (TTM) 2.07%
GM 10.83%
OM growth 3Y-29.13%
OM growth 5Y-20.77%
PM growth 3Y-47.55%
PM growth 5Y-27.44%
GM growth 3Y-19.66%
GM growth 5Y-13.11%
IMOS Yearly Profit, Operating, Gross MarginsIMOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. IMOS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for IMOS has been reduced compared to 1 year ago.
  • The number of shares outstanding for IMOS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, IMOS has a worse debt to assets ratio.
IMOS Yearly Shares OutstandingIMOS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IMOS Yearly Total Debt VS Total AssetsIMOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • The Debt to FCF ratio of IMOS is 112.43, which is on the high side as it means it would take IMOS, 112.43 years of fcf income to pay off all of its debts.
  • IMOS has a Debt to FCF ratio (112.43) which is in line with its industry peers.
  • IMOS has a Debt/Equity ratio of 0.55. This is a neutral value indicating IMOS is somewhat dependend on debt financing.
  • IMOS has a Debt to Equity ratio of 0.55. This is in the lower half of the industry: IMOS underperforms 70.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 112.43
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
IMOS Yearly LT Debt VS Equity VS FCFIMOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • IMOS has a Current Ratio of 2.40. This indicates that IMOS is financially healthy and has no problem in meeting its short term obligations.
  • IMOS has a Current ratio of 2.40. This is in the lower half of the industry: IMOS underperforms 61.74% of its industry peers.
  • A Quick Ratio of 2.08 indicates that IMOS has no problem at all paying its short term obligations.
  • IMOS has a Quick ratio of 2.08. This is comparable to the rest of the industry: IMOS outperforms 50.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.08
IMOS Yearly Current Assets VS Current LiabilitesIMOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IMOS Growth Analysis

3.1 Past

  • IMOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.05%.
  • IMOS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.36% yearly.
  • The Revenue has been growing slightly by 5.45% in the past year.
  • The Revenue has been growing slightly by 0.79% on average over the past years.
EPS 1Y (TTM)-64.05%
EPS 3Y-46.68%
EPS 5Y-26.36%
EPS Q2Q%128.18%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y0.59%
Revenue growth 5Y0.79%
Sales Q2Q%20.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 151.76% on average over the next years. This is a very strong growth
  • IMOS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.15% yearly.
EPS Next Y448.75%
EPS Next 2Y151.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.82%
Revenue Next 2Y12.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMOS Yearly Revenue VS EstimatesIMOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
IMOS Yearly EPS VS EstimatesIMOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20 40 60 80 100

More info and screens

Find the best growth stocksShow best growing peers

1

4. IMOS Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
IMOS Price Earnings VS Forward Price EarningsIMOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMOS Per share dataIMOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

  • IMOS's earnings are expected to grow with 151.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y151.76%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMOS Dividend Analysis

5.1 Amount

  • No dividends for IMOS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMOS Fundamentals: All Metrics, Ratios and Statistics

CHIPMOS TECHNOLOGIES INC-ADR

NASDAQ:IMOS (3/16/2026, 8:00:03 PM)

39.75

+2.02 (+5.35%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-25
Earnings (Next)05-11
Inst Owners10.56%
Inst Owner Change-2.53%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.38B
Revenue(TTM)23.93B
Net Income(TTM)495.12M
Analysts85.45
Price Target35.27 (-11.27%)
Short Float %0.06%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)-7.44%
DP176.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)146.02%
Min EPS beat(2)33.36%
Max EPS beat(2)258.67%
EPS beat(4)3
Avg EPS beat(4)-3.87%
Min EPS beat(4)-312.1%
Max EPS beat(4)258.67%
EPS beat(8)3
Avg EPS beat(8)-18.45%
EPS beat(12)5
Avg EPS beat(12)-8.07%
EPS beat(16)7
Avg EPS beat(16)-8.45%
Revenue beat(2)2
Avg Revenue beat(2)1.55%
Min Revenue beat(2)0.93%
Max Revenue beat(2)2.18%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-4.63%
Max Revenue beat(4)2.18%
Revenue beat(8)4
Avg Revenue beat(8)-1.74%
Revenue beat(12)7
Avg Revenue beat(12)-0.71%
Revenue beat(16)8
Avg Revenue beat(16)-1.91%
PT rev (1m)-4.27%
PT rev (3m)25.08%
EPS NQ rev (1m)17.95%
EPS NQ rev (3m)78.22%
EPS NY rev (1m)37.11%
EPS NY rev (3m)75.44%
Revenue NQ rev (1m)5.78%
Revenue NQ rev (3m)9.11%
Revenue NY rev (1m)8.72%
Revenue NY rev (3m)8.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 2.06%
ROCE 3.28%
ROIC 2.59%
ROICexc 4.31%
ROICexgc 4.31%
OM 4.77%
PM (TTM) 2.07%
GM 10.83%
FCFM 0.61%
ROA(3y)2.77%
ROA(5y)5.54%
ROE(3y)5.11%
ROE(5y)9.94%
ROIC(3y)3.23%
ROIC(5y)5.95%
ROICexc(3y)5.15%
ROICexc(5y)8.15%
ROICexgc(3y)5.15%
ROICexgc(5y)8.15%
ROCE(3y)3.88%
ROCE(5y)7.09%
ROICexgc growth 3Y-23.01%
ROICexgc growth 5Y-18.47%
ROICexc growth 3Y-23.01%
ROICexc growth 5Y-18.47%
OM growth 3Y-29.13%
OM growth 5Y-20.77%
PM growth 3Y-47.55%
PM growth 5Y-27.44%
GM growth 3Y-19.66%
GM growth 5Y-13.11%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 112.43
Debt/EBITDA 2.13
Cap/Depr 75.5%
Cap/Sales 16.09%
Interest Coverage 4.25
Cash Conversion 64.01%
Profit Quality 29.33%
Current Ratio 2.4
Quick Ratio 2.08
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)81.48%
Cap/Depr(5y)94.05%
Cap/Sales(3y)17.62%
Cap/Sales(5y)18.86%
Profit Quality(3y)92.16%
Profit Quality(5y)84.21%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.05%
EPS 3Y-46.68%
EPS 5Y-26.36%
EPS Q2Q%128.18%
EPS Next Y448.75%
EPS Next 2Y151.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.45%
Revenue growth 3Y0.59%
Revenue growth 5Y0.79%
Sales Q2Q%20.77%
Revenue Next Year19.82%
Revenue Next 2Y12.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.3%
EBIT growth 3Y-28.72%
EBIT growth 5Y-20.14%
EBIT Next Year806.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.1%
FCF growth 3Y-66.66%
FCF growth 5Y-40.69%
OCF growth 1Y-32.73%
OCF growth 3Y-22.59%
OCF growth 5Y-7.62%

CHIPMOS TECHNOLOGIES INC-ADR / IMOS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CHIPMOS TECHNOLOGIES INC-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to IMOS.


What is the valuation status of CHIPMOS TECHNOLOGIES INC-ADR (IMOS) stock?

ChartMill assigns a valuation rating of 1 / 10 to CHIPMOS TECHNOLOGIES INC-ADR (IMOS). This can be considered as Overvalued.


What is the profitability of IMOS stock?

CHIPMOS TECHNOLOGIES INC-ADR (IMOS) has a profitability rating of 3 / 10.


Can you provide the financial health for IMOS stock?

The financial health rating of CHIPMOS TECHNOLOGIES INC-ADR (IMOS) is 4 / 10.


Can you provide the dividend sustainability for IMOS stock?

The dividend rating of CHIPMOS TECHNOLOGIES INC-ADR (IMOS) is 0 / 10 and the dividend payout ratio is 176.26%.